top of page

IRIS

  • romanberenblyum
  • May 1, 2017
  • 1 min read

1 May 2017

IRIS-Forskningsinvest AS has signed an agreement with Hydrogen Source AS and transferred all patent and technology commercialization rights for “In situ hydrogen generation” technology to Hydrogen Source AS.

 
 
 

Comments


bottom of page